title: Severe Aspergillus endocarditis in a lung transplant recipient with a five-year survival.
abstract: We report the case of a patient with cystic fibrosis who underwent lung transplant and developed Aspergillus endocarditis and cutaneous relapse. Long-term survival was achieved with surgical and prolonged antifungal treatment. This case report emphasizes the recommendation of life-long antifungal treatment in transplant recipients who survive an episode of fungal endocarditis.
authors.affiliation: Department of Pulmonary Transplantation, Foch Hospital, Suresnes, France. bruno.philippe@ch-pontoise.fr
authors.forename: B
authors.initials: B
authors.lastname: Philippe
authors.forename: D
authors.initials: D
authors.lastname: Grenet
authors.forename: P
authors.initials: P
authors.lastname: Honderlick
authors.forename: E
authors.initials: E
authors.lastname: Longchampt
authors.forename: B
authors.initials: B
authors.lastname: Dupont
authors.forename: C
authors.initials: C
authors.lastname: Picard
authors.forename: M
authors.initials: M
authors.lastname: Stern
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D001232:Aspergillus fumigatus / Q000187:drug effects / Q000302:isolation & purification*; D003550:Cystic Fibrosis / Q000382:microbiology*; D004696:Endocarditis / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D005260:Female; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects*; D012720:Severity of Illness Index; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents